Suchergebnisse - "Qian, Hai"

PubPharm (29)

1

Design, synthesis and bioactivity evaluation of novel fusion peptides and their CPT conjugates inducing effective anti-tumor responses on HER2 positive tumors

enthalten in: European journal of medicinal chemistry | 2024

von Zhou, J. | Xie, Z. | Wang, J. | +6

2

In Silico Exploration and Biological Evaluation of Bispecific Peptides Derived from Anti-HER2 Antibodies and Peptide-Camptothecin Conjugates for HER2-Positive Breast Cancer

enthalten in: Journal of medicinal chemistry | 2022

von Zhou, J. | Bian, X. | Kan, Z. | +6

3

Secretory type II cGMP-dependent protein kinase blocks activation of PDGFRβ via Ser254 in gastric cancer cells

enthalten in: Cell biology international | 2022

von Pang, J. | Li, G. | Qian, H. | +2

4

Structure-based discovery of receptor tyrosine kinase AXL degraders with excellent anti-tumor activity by selectively degrading AXL and inducing methuosis

enthalten in: European journal of medicinal chemistry | 2022

von Shi, W. | Feng, Z. | Chi, F. | +8

5

Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment

enthalten in: Journal of medicinal chemistry | 2022

von Li, D. | Tu, Y. | Jin, K. | +13

6

PKG II secreted via the classical endoplasmic reticulum-Golgi apparatus secretory pathway blocks the activation of EGFR through phosporalting its threonine 406 and has an anti-tumor effect

enthalten in: Frontiers in bioscience (Landmark edition) | 2022

von Wu, Y. | Wu, M. | Wang, Z. | +10

7

A designed cyclic peptide based on Trastuzumab used to construct peptide-drug conjugates for its HER2-targeting ability

enthalten in: Bioorganic chemistry | 2021

von Zhou, J. | Zou, Y. | Cai, Y. | +4

8

Type II cGMP-dependent protein kinase phosphorylates EGFR at threonine 669 and thereby inhibits its activation

enthalten in: Biochemical and biophysical research communications | 2019

von Lan, T. | Pang, J. | Wang, Z. | +4

9

Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2

enthalten in: European journal of medicinal chemistry | 2018

von Shi, W. | Qiang, H. | Huang, D. | +3

ErratumIn: Eur J Med Chem. 2020 Jan 1;185:111799. - PMID 31670202

10

PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells

enthalten in: Cell biology international | 2018

von Wang, Y. | Appiah-Kubi, K. | Lan, T. | +7